GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2026)
GE HealthCare Technologies (GEHC) posted EBITDA Margin of 10.04% for Q1 2026, down 30.85% on a QoQ basis from 14.51% in Q4 2025, and down 313.0% year-over-year from 4.71% in Q1 2025.
GE HealthCare Technologies (GEHC) EBITDA Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' EBITDA Margin history runs 5 years deep, the most recent figure standing at 10.04% for Q1 2026.
- Quarterly EBITDA Margin fell 313.0% year-over-year to 10.04% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.63% (down 108.0% YoY) and the FY2025 annual result came in at 13.4%, up 5.0% from the prior year.
- EBITDA Margin was 10.04% for Q1 2026 at GE HealthCare Technologies, down from 14.51% in the prior quarter.
- Across five years, EBITDA Margin topped out at 15.74% in Q4 2022 and bottomed at 10.04% in Q1 2026.
- A 5-year average of 13.01% and a median of 13.06% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2024 — EBITDA Margin surged 182 bps — and 2026, when it plunged 313 bps.
- GE HealthCare Technologies' EBITDA Margin stood at 15.74% in 2022, then dropped by 16 bps to 13.23% in 2023, then climbed by 14 bps to 15.06% in 2024, then retreated by 4 bps to 14.51% in 2025, then sank by 31 bps to 10.04% in 2026.
- Business Quant data shows GEHC's EBITDA Margin at 10.04% in Q1 2026, 14.51% in Q4 2025, and 12.7% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | 10.04% |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 6.17% |
| 10 | Steris | 21.46 Bn | 21.02 Bn | 697.10 Mn | 19.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.04% |
| Dec 31, 2025 | 14.51% |
| Sep 30, 2025 | 12.70% |
| Jun 30, 2025 | 13.06% |
| Mar 31, 2025 | 13.17% |
| Dec 31, 2024 | 15.06% |
| Sep 30, 2024 | 13.90% |
| Jun 30, 2024 | 12.56% |
| Mar 31, 2024 | 11.61% |
| Dec 31, 2023 | 13.23% |
| Sep 30, 2023 | 12.80% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | 11.88% |
| Dec 31, 2022 | 15.74% |
| Sep 30, 2022 | 13.22% |
| Jun 30, 2022 | 14.07% |
| Mar 31, 2022 | 11.72% |